AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimigoal-M2 Tablet PR

Prescription Icon
Prescription Required

Marketer

Metcure Remedies Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimigoal-M2 Tablet PR

Duo-diabetic medication, Glimigoal-M2 Tablet PR, manages type 2 diabetes in adults by combining two anti-diabetic agents. It effectively regulates blood glucose. Administer this medication with meals, consistently at the same time daily for optimal results. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially causing kidney complications, vision loss, neuropathy, and limb damage. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight control as advised by your doctor. Lifestyle modifications significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Maintain regular meals, carry a rapid-acting glucose source (e.g., sugary snacks or juice), and limit alcohol consumption to mitigate this risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. Contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose checks and potential blood tests (to assess blood cell counts and liver function) are recommended under your doctor's guidance.

Primary Ingredients of Glimigoal-M2 Tablet PR

No text provided. Please provide the text you want me to rephrase.

Uses of Glimigoal-M2 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimigoal-M2 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidance. Administer Glimigoal-M2 Tablet PR with a meal.

Common Side effects of Glimigoal-M2 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimigoal-M2 Tablet PR:

Follow your doctor's instructions or consult the product information leaflet for dosage guidance. Take Glimigoal-M2 Tablet PR with food.

How Glimigoal-M2 Tablet PR works:

Glimigoal-M2 Tablet PR combines glimepiride and metformin, two agents that manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin, a biguanide, acts through multiple mechanisms: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glimigoal-M2 Tablet PR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimigoal-M2 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Using Glimigoal-M2 Tablet PR while breastfeeding is contraindicated due to potential infant toxicity. Evidence indicates the medication may harm the nursing infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimigoal-M2 Tablet PR cautiously, potentially requiring dosage modification. Physician consultation is recommended. Glimigoal-M2 Tablet PR is contraindicated in patients with severe renal disease. Routine monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimigoal-M2 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician. A reduced starting dose is typically advised for those with mild to moderate liver disease; however, its use is contraindicated in severe cases.

What if you forget to take Glimigoal-M2 Tablet PR :

Should you forget a dose of Glimigoal-M2 Tablet PR, take it immediately if you remember. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Glimigoal-M2 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimigoal-M2 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimigoal-M2 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but dangerous side effect is more likely in patients with kidney disease, older individuals, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimigoal-M2 Tablet PR and seek immediate medical attention.
Glimigoal-M2 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for treating type 1 DM.
Glimigoal-M2 Tablet PR may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimigoal-M2 Tablet PR use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, neurological issues like numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimigoal-M2 Tablet PR can indeed lower blood sugar, potentially causing hypoglycemia. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimigoal-M2 Tablet PR and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimigoal-M2 Tablet PR
54
MRP 66
18% off